IHH Healthcare submits fresh bid for Fortis

NEW DELHI: Malaysia’s IHH Healthcare Berhad on Tuesday said it has made a fresh binding offer to the board of Fortis Healthcare.

The binding offer is valid till July 16, 2018, IHH Healthcare Berhad said in a regulatory filing.

IHH today issued a letter to the board of Fortis “setting out a binding offer, which supersedes and replaces the enhanced revised proposal,” it added.

“In the event IHH does not receive any response from Fortis by no later than 5 pm IST on July 16 2018, the binding offer shall be deemed to have been withdrawn,” IHH Healthcare Berhad said.

The company, however, did not provide any details about the size of the bid.

Cash-strapped Fortis Healthcare had set July 3 as the deadline for the submission of the fresh binding bids. The company had earlier scrapped its decision to opt for the offer by the Munjal-Burman combine to invest Rs 1,800 crore in the company.

Earlier, Fortis Healthcare had received binding bids from four suitors — Munjal-Burman combine, TPG-Manipal consortium, Malaysia’s IHH Healthcare Berhad and KKR-backed Radiant Life Care.

China’s Fosun Healthcare had not made a binding bid for the company.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra